Back to top
more

QIAGEN (QGEN)

(Delayed Data from NYSE)

$36.95 USD

36.95
1,964,098

+0.37 (1.01%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $36.96 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now

by Zacks Equity Research

Investors can retain QIAGEN (QGEN) stock for now, thanks to its solid prospects.

Zacks Equity Research

Company News For Dec 27, 2019

by Zacks Equity Research

Companies In The News Are: QGEN, IMMU, CANF, SBPH

Zacks Equity Research

OSMT vs. QGEN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

OSMT vs. QGEN: Which Stock Is the Better Value Option?

Zacks Equity Research

QIAGEN and DiaSorin Get FDA Approval for LIAISON QFT-Plus

by Zacks Equity Research

QIAGEN (QGEN) and DiaSorin begin the commercial launch of the QFT-Plus test in the United States, following the FDA clearance.

Zacks Equity Research

QIAGEN Expands Existing Deal With LabCorp for Better Treatment

by Zacks Equity Research

QIAGEN (QGEN) announces the expansion of partnership with LabCorp (LH) to make genetic information available for clinical and research purposes.

Zacks Equity Research

OSMT or QGEN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

OSMT vs. QGEN: Which Stock Is the Better Value Option?

Zacks Equity Research

QIAGEN Rides on Solid QuantiFERON-TB Sales Amid Several Woes

by Zacks Equity Research

QIAGEN (QGEN) pins hopes on its key strategic collaborations with Hamilton Robotics and Tecan for the pre-analytical handling of blood tubes.

Zacks Equity Research

QIAGEN (QGEN) Catches Eye: Stock Jumps 9.9%

by Zacks Equity Research

QIAGEN (QGEN) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Equity Research

QIAGEN (QGEN) Beats Q3 Earnings Estimates, Cuts Revenue View

by Zacks Equity Research

We are impressed with QIAGEN's (QGEN) year-over-year growth across majority of operating segments in Q3.

Zacks Equity Research

Qiagen (QGEN) Tops Q3 Earnings Estimates

by Zacks Equity Research

Qiagen (QGEN) delivered earnings and revenue surprises of 2.86% and -0.26%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?